For sales

📢Highlights from the Week of 8th–15th September, 2025  in the world of pharma and healthcare! 🗞️👀

Highlights from the Week of 8th-15th September, 2025 VYUHPHARMA Johnson&Johnson FDA approves Johnson & Johnson's INLEXZO to transform bladder cancer treatment (FDA, Approval) croma Fon creators of beauty. Croma-Pharma's Obagi saypha® MagIQ™™ receives FDA approval in the U.S. (FDA, Approval) (EMA, Approval PTX PARTNER HERAPEUTICS EMA approves Partner Therapeutics' IMREPLYS for radiation exposure treatment Neurim PHARMACEUTICALS (Health Canada, Approval Health Canada approves Neurim Pharmaceuticals' Slenyto for insomnia in children with autism spectrum disorder and Smith-Magenis Syndrome Pg 1/2 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.